NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,470,328 | -74.9% | 81,944 | -63.2% | 0.00% | -71.4% |
| Q1 2023 | $13,827,319 | -29.8% | 222,698 | +9.3% | 0.01% | -36.4% |
| Q4 2022 | $19,704,463 | +25.7% | 203,769 | +10.4% | 0.01% | +22.2% |
| Q3 2022 | $15,681,000 | +33.8% | 184,585 | +14.7% | 0.01% | 0.0% |
| Q2 2022 | $11,724,000 | +67.4% | 160,967 | +97.7% | 0.01% | +80.0% |
| Q1 2022 | $7,003,000 | +39.8% | 81,400 | +13.3% | 0.01% | +66.7% |
| Q4 2021 | $5,011,000 | -37.5% | 71,872 | +4.1% | 0.00% | -50.0% |
| Q3 2021 | $8,019,000 | -36.7% | 69,030 | +20.9% | 0.01% | -33.3% |
| Q2 2021 | $12,665,000 | – | 57,090 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |